Budget impact analysis on erythropoiesis–stimulating agents use for the management of chemotherapy-induced anaemia in Greece

@inproceedings{Nikolaidi2013BudgetIA,
  title={Budget impact analysis on erythropoiesis–stimulating agents use for the management of chemotherapy-induced anaemia in Greece},
  author={Eleftheria Nikolaidi and Magdalini Hatzikou and Mary A. Geitona},
  booktitle={Cost effectiveness and resource allocation : C/E},
  year={2013}
}
BACKGROUND Chemotherapy-induced anaemia is a common and significant complication of chemotherapy treatment. Blood transfusion and administration of Erythropoiesis-Stimulating Agents (ESAs) either alone or in combination with iron are the most widely used therapeutic options. In Greece, ESAs are among the top ten therapeutic groups with the highest… CONTINUE READING